Ondine Biomedical Inc.
OBIMF
$0.25
$0.0847.06%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -51.96% | -55.90% | -62.49% | -44.89% | -30.31% |
| Total Depreciation and Amortization | 2.30% | 1.52% | 1.34% | -2.88% | -5.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.97% | 63.68% | 245.64% | 177.93% | 135.84% |
| Change in Net Operating Assets | 96.46% | 162.94% | 322.69% | 933.69% | 722.62% |
| Cash from Operations | -51.23% | -47.30% | -43.51% | -25.62% | -11.66% |
| Capital Expenditure | -1,039.19% | -498.82% | -78.13% | 82.89% | 94.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,039.19% | -498.82% | -78.13% | 82.89% | 94.36% |
| Total Debt Issued | -- | 0.00% | -- | -- | -- |
| Total Debt Repaid | 60.58% | 4.70% | -117.73% | -121.68% | -125.76% |
| Issuance of Common Stock | 13.06% | 43.36% | 106.84% | 187.55% | 367.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.38% | 12.42% | -12.24% | -70.97% | -175.86% |
| Cash from Financing | 10.21% | 45.61% | 131.17% | 225.76% | 463.90% |
| Foreign Exchange rate Adjustments | -31.17% | 85.90% | 908.90% | 12,720.51% | 705.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.50% | 36.43% | 230.58% | 181.21% | 165.08% |